s-(4-bromobenzyl)glutathione has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
*Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Silva, C; Daunes, S | 1 |
1 other study(ies) available for s-(4-bromobenzyl)glutathione and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Structure-activity study on the in vitro antiprotozoal activity of glutathione derivatives.
Topics: Animals; Antiprotozoal Agents; Cell Survival; Esterification; Female; Glutathione; Humans; Leishmania donovani; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrophages, Peritoneal; Mice; Spermidine; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma cruzi; Tumor Cells, Cultured | 2000 |